Neurotrimin function inhibitor
AssigneeThe University of Tokyo
InventorsTetsu AKIYAMA, Yuki KAMOSHIDA, Tomoatsu HAYASHI, Yusuke YAMAZUMI, Takeaki ODA, Mima SHIKANAI
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe University of Tokyo
InventorsTetsu AKIYAMA, Yuki KAMOSHIDA, Tomoatsu HAYASHI, Yusuke YAMAZUMI, Takeaki ODA, Mima SHIKANAI
Estimating the term…
It is an object of the present invention to provide a cellular senescence-suppressing agent, and a preventive or therapeutic agent for diseases, etc. provided by cellular senescence. More specifically, the present invention relates to a cellular senescence-suppressing agent, comprising, as an active ingredient, an agent for inhibiting the function of NTM (Neurotrimin), and a medicament, etc., comprising the cellular senescence-suppressing agent. Moreover, the present invention relates to an antibody that suppresses senescence. Furthermore, the present invention relates to a method of screening for a substance that suppresses cellular senescence.
A cellular senescence-suppressing agent, comprising, as an active ingredient, an NTM (Neurotrimin) function inhibitor.
An antibody or an antigen-binding fragment thereof, wherein the amino acid sequences of CDRs (complementarity determining regions) 1 to 3 satisfy any of the following (A), (B), (C), (D) or (E):
A method of screening for a substance that suppresses cellular senescence, comprising the following (a) and (b):
Dependencies are inferred from the claim text.